KLF2 and metabolic dysfunction-associated steatotic liver disease: The expression of KLF2 [72], KLF9 [77], and KLF14 [59] is increased in response to HFD in mice, and their inhibition attenuates steatohepatitis, indicating their involvement in NAFLD pathogenesis.